...mmm,I liked this line GC.
'a phase two trial will demonstrate therapeutic efficacy of our patch systems much earlier, and provide us with greater commercial flexibility should we decide to licence one of our portfolio products at that stage'
..should we decide!...get in line pharma joe
- Forums
- ASX - By Stock
- AVE
- mylan t/o of agila -> poh
mylan t/o of agila -> poh, page-27
Featured News
Add AVE (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.507M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.3¢ | $1.32K | 440K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
30 | 40522233 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 40065430 | 31 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
30 | 40522233 | 0.002 |
32 | 75717741 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 39315430 | 30 |
0.004 | 30596565 | 18 |
0.005 | 10575266 | 9 |
0.006 | 10908952 | 10 |
0.007 | 13396103 | 7 |
Last trade - 14.05pm 15/11/2024 (20 minute delay) ? |
Featured News
AVE (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online